This page shows the latest clinical benefit news and features for those working in and with pharma, biotech and healthcare.
In the final day 29 results, the antiviral drug plus standard therapy was able to cut the time to clinical recovery by five days compared to placebo, with a median time ... journals validating the clinical benefit of remdesivir”.
In the final day 29 results, remdesivir plus standard-of-care treatment were able to cut the time to clinical recovery by five days compared to placebo, with a median time ... The drugmaker told Reuters that “the emerging (WHO) data appears inconsistent
The emerging (WHO) data appears inconsistent, with more robust evidence from multiple randomised, controlled studies published in peer-reviewed journals validating the clinical benefit of remdesivir,” Gilead told Reuters. ... In addition to the 62%
Initially, NICE turned down Mayzent due to a lack of clinical evidence for its clinical benefit in SPMS and also a lack of cost-efficiency evidence. ... unmet clinical need,” said Meindert Boysen, deputy chief executive and director of the Centre for
The CHRYSALIS study investigators assessed the efficacy of the combination treatment using overall response rate (ORR) markers, as well as clinical benefit rate, duration of response and the safety profile of ... response, representing a clinical benefit
Following the approval, NS Pharma is required to conduct a confirmatory clinical trial to demonstrate the drug’s clinical benefit. ... Like NS Pharma, Sarepta is conducting a confirmatory trial of Vyondys 53 after winning initial approval to determine
More from news
Approximately 1 fully matching, plus 164 partially matching documents found.
Baseline survival times are longer in early-stage disease, and other measures of clinical benefit become relevant such as avoidance of recurrence and quality of life. ... Which alternative endpoints can assess clinical benefit in early-stage disease?
The analysis of the expanded data set for one of the phase 3 trials, EMERGE, linked aducanumab to improvements on a clinical dementia scale. ... The preponderance of the data indicates aducanumab doesn’t provide a clinical benefit,’ Skorney wrote in
Every clinical trial has an endpoint, a measure used to determine if the drug in question provides therapeutic benefit. ... measure safety, efficacy and clinical benefit of a medicine in a trial.
The scheme. The PRIME scheme is for medicines that have real promise, defined by the EMA as medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients ... Companies who want to benefit from the scheme have to
This could have far-reaching consequences for some players in the pharmaceutical industry who may find their product pricing to be untenable when the cost/clinical benefit calculus becomes totally transparent.
More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.
In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203. ... Not only will we benefit from her clinical capabilities in our ongoing pivotal study of
Trade body for clinical research organisation elects Ciaran Murray. The global trade body for clinical research organisations has elected ICON's CEO Ciaran Murray as chairman. ... I look forward to continuing the work that ACRO has done in promoting our
The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in the life sciences industry, which includes spells in research at Roche, Glaxo and SmithKline.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
the areas in which sponsors can use these emotions to their benefit are:. ... It’s important to give participants a personal reason for taking part in clinical trials.
The same applies to many more therapeutic areas. Moreover, even when a substantial clinical benefit is proven, payers will tend to position the product in second line, to be used when ... In some cases, for instance, when it will be essential to show
A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest. ... assessing the clinical benefit of oncology
study[13] the benefit common to both was a 50% reduction in mortality risk. ... Most apparent may be the monetary cost of medicines which, through nonadherence, are wasted and don’t lead to their intended clinical benefit.
uncertainties about the criteria to identify the population of patients most likely to benefit from the product in clinical practice. ... the product hasn’t been studied in the normal combination. selected patients didn’t include the frail ones, so
More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....